| Reliable detection of mismatch repair deficiency in colorectal cancers using mutational load in next-generation sequencing panels ZK Stadler, F Battaglin, S Middha, JF Hechtman, C Tran, A Cercek, ... Journal of Clinical Oncology 34 (18), 2141-2147, 2016 | 247 | 2016 |
| Microsatellite instability in colorectal cancer: overview of its clinical significance and novel perspectives F Battaglin, M Naseem, HJ Lenz, ME Salem Clinical advances in hematology & oncology: H&O 16 (11), 735, 2018 | 245 | 2018 |
| Outlooks on Epstein-Barr virus associated gastric cancer M Naseem, A Barzi, C Brezden-Masley, A Puccini, MD Berger, ... Cancer treatment reviews 66, 15-22, 2018 | 222 | 2018 |
| B cell and B cell-related pathways for novel cancer treatments R Tokunaga, M Naseem, JH Lo, F Battaglin, S Soni, A Puccini, MD Berger, ... Cancer treatment reviews 73, 10-19, 2019 | 190 | 2019 |
| Heterogeneity of acquired resistance to anti-EGFR monoclonal antibodies in patients with metastatic colorectal cancer F Pietrantonio, C Vernieri, G Siravegna, A Mennitto, R Berenato, ... Clinical cancer research 23 (10), 2414-2422, 2017 | 178 | 2017 |
| Molecular insight of regorafenib treatment for colorectal cancer H Arai, F Battaglin, J Wang, JH Lo, S Soni, W Zhang, HJ Lenz Cancer treatment reviews 81, 101912, 2019 | 149 | 2019 |
| Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild-Type Metastatic … R Moretto, C Cremolini, D Rossini, F Pietrantonio, F Battaglin, A Mennitto, ... The oncologist 21 (8), 988-994, 2016 | 144 | 2016 |
| Safety and tolerability of c-MET inhibitors in cancer A Puccini, NI Marín-Ramos, F Bergamo, M Schirripa, S Lonardi, HJ Lenz, ... Drug safety 42, 211-233, 2019 | 110 | 2019 |
| Molecular profiling of appendiceal adenocarcinoma and comparison with right-sided and left-sided colorectal cancer R Tokunaga, J Xiu, C Johnston, RM Goldberg, PA Philip, A Seeber, ... Clinical Cancer Research 25 (10), 3096-3103, 2019 | 86 | 2019 |
| Comprehensive genomic profiling of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) A Puccini, K Poorman, ME Salem, D Soldato, A Seeber, RM Goldberg, ... Clinical Cancer Research 26 (22), 5943-5951, 2020 | 84 | 2020 |
| Molecular profile of BRCA-mutated biliary tract cancers G Spizzo, A Puccini, J Xiu, RM Goldberg, A Grothey, AF Shields, SP Arora, ... Esmo Open 5 (3), e000682, 2020 | 82 | 2020 |
| Colorectal cancer: epigenetic alterations and their clinical implications A Puccini, MD Berger, M Naseem, R Tokunaga, F Battaglin, S Cao, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1868 (2), 439-448, 2017 | 81 | 2017 |
| Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions F Battaglin, M Naseem, A Puccini, HJ Lenz Cancer Cell International 18, 1-18, 2018 | 76 | 2018 |
| Clocking cancer: the circadian clock as a target in cancer therapy F Battaglin, P Chan, Y Pan, S Soni, M Qu, ER Spiller, S Castanon, ... Oncogene 40 (18), 3187-3200, 2021 | 67 | 2021 |
| The role of tumor angiogenesis as a therapeutic target in colorectal cancer F Battaglin, A Puccini, R Intini, M Schirripa, A Ferro, F Bergamo, S Lonardi, ... Expert review of anticancer therapy 18 (3), 251-266, 2018 | 60 | 2018 |
| Estimating 12-week death probability in patients with refractory metastatic colorectal cancer: The Colon Life nomogram F Pietrantonio, R Miceli, L Rimassa, S Lonardi, G Aprile, A Mennitto, ... Annals of Oncology 28 (3), 555-561, 2017 | 52 | 2017 |
| The impact of ARID1A mutation on molecular characteristics in colorectal cancer R Tokunaga, J Xiu, RM Goldberg, PA Philip, A Seeber, F Battaglin, H Arai, ... European Journal of Cancer 140, 119-129, 2020 | 50 | 2020 |
| Aryl hydrocarbon receptor nuclear translocator-like (ARNTL/BMAL1) is associated with bevacizumab resistance in colorectal cancer via regulation of vascular endothelial growth … E Burgermeister, F Battaglin, F Eladly, W Wu, F Herweck, N Schulte, ... EBioMedicine 45, 139-154, 2019 | 50 | 2019 |
| Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world V Fanotto, S Cordio, G Pasquini, C Fontanella, L Rimassa, F Leone, ... Gastric Cancer 20, 825-833, 2017 | 50 | 2017 |
| Management of advanced small bowel cancer A Puccini, F Battaglin, HJ Lenz Current treatment options in oncology 19, 1-14, 2018 | 42 | 2018 |